Payment overview · 2025
General Payments
$35.67
2 reported records · 2 companies
Healthcare provider profile · identity verified
Steven Carmichael Brandon, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · STARKVILLE, MS · NPI 1225017239
Verified facts
What the public records show
CMS Open Payments records show Steven Carmichael Brandon, M.D. received $35.67 in general payments during 2025 across 2 reported records.
Dexcom, Inc. accounted for 59.1% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Dexcom, Inc. | Unresolved — no canonical attribution shown | $21.07 | 59.1% | 1 | 2025 |
| Amgen Inc. | Unresolved — no canonical attribution shown | $14.60 | 40.9% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $35.67 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Dexcom G6 Transmitter Normalized: dexcom g6 transmitter |
Medical Supply | Dexcom, Inc. | $21.07 | 1 | 2025 |
Source payment records
|
|||||
| EVENITY Normalized: evenity |
Biological | Amgen Inc. | $14.60 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Amlodipine Besylate | Amlodipine Besylate | 532 | 141 |
| Atorvastatin Calcium | Atorvastatin Calcium | 442 | 104 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 391 | 115 |
| Metoprolol Succinate | Metoprolol Succinate | 335 | 91 |
| Levothyroxine Sodium | Levothyroxine Sodium | 308 | 71 |
| Hydrochlorothiazide | Hydrochlorothiazide | 297 | 79 |
| Metformin Hcl | Metformin Hcl | 283 | 81 |
| Losartan Potassium | Losartan Potassium | 273 | 80 |
| Lisinopril | Lisinopril | 251 | 68 |
| Potassium Chloride | Potassium Chloride | 251 | 59 |
| Omeprazole | Omeprazole | 238 | 63 |
| Eliquis | Apixaban | 216 | 23 |
| Famotidine | Famotidine | 188 | 35 |
| Gabapentin | Gabapentin | 176 | 51 |
| Pantoprazole Sodium | Pantoprazole Sodium | 158 | 42 |
| Fluoxetine Hcl | Fluoxetine Hcl | 154 | 36 |
| Furosemide | Furosemide | 152 | 42 |
| Tamsulosin Hcl | Tamsulosin Hcl | 148 | 37 |
| Montelukast Sodium | Montelukast Sodium | 146 | 42 |
| Simvastatin | Simvastatin | 142 | 39 |
| Pravastatin Sodium | Pravastatin Sodium | 117 | 28 |
| Donepezil Hcl | Donepezil Hcl | 106 | 13 |
| Duloxetine Hcl | Duloxetine Hcl | 103 | 23 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 98 | 23 |
| Allopurinol | Allopurinol | 95 | 29 |
| Metoprolol Tartrate | Metoprolol Tartrate | 93 | 22 |
| Jardiance | Empagliflozin | 92 | 18 |
| Hydralazine Hcl | Hydralazine Hcl | 91 | 24 |
| Carvedilol | Carvedilol | 88 | 21 |
| Escitalopram Oxalate | Escitalopram Oxalate | 86 | 17 |
| Ezetimibe | Ezetimibe | 85 | 25 |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 78 | 15 |
| Fluticasone Propionate | Fluticasone Propionate | 73 | 32 |
| Finasteride | Finasteride | 68 | 15 |
| Farxiga | Dapagliflozin Propanediol | 67 | 15 |
| Sertraline Hcl | Sertraline Hcl | 66 | 23 |
| Januvia | Sitagliptin Phosphate | 64 | suppressed |
| Novolog Flexpen | Insulin Aspart | 59 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 56 | 16 |
| Clopidogrel | Clopidogrel Bisulfate | 53 | 14 |
| Prednisone | Prednisone | 53 | 41 |
| Meclizine Hcl | Meclizine Hcl | 52 | 13 |
| Memantine Hcl | Memantine Hcl | 52 | suppressed |
| Buspirone Hcl | Buspirone Hcl | 51 | 14 |
| Olanzapine | Olanzapine | 50 | suppressed |
| Meloxicam | Meloxicam | 48 | 15 |
| Trazodone Hcl | Trazodone Hcl | 48 | 13 |
| Alprazolam | Alprazolam | 47 | 12 |
| Mirtazapine | Mirtazapine | 46 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 46 | suppressed |
| Topiramate | Topiramate | 44 | suppressed |
| Irbesartan | Irbesartan | 43 | 11 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 43 | 12 |
| Glimepiride | Glimepiride | 40 | 14 |
| Tradjenta | Linagliptin | 40 | suppressed |
| Ibuprofen | Ibuprofen | 38 | 18 |
| Spironolactone | Spironolactone | 38 | 13 |
| Bupropion Xl | Bupropion Hcl | 37 | 15 |
| Levetiracetam | Levetiracetam | 37 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 36 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 36 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 35 | suppressed |
| Entresto | Sacubitril/Valsartan | 34 | suppressed |
| Nifedipine Er | Nifedipine | 34 | suppressed |
| Synthroid | Levothyroxine Sodium | 34 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 31 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 30 | suppressed |
| Colchicine | Colchicine | 30 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 30 | suppressed |
| Chlorthalidone | Chlorthalidone | 29 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 29 | suppressed |
| Rybelsus | Semaglutide | 28 | suppressed |
| Valsartan | Valsartan | 28 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 27 | suppressed |
| Phenytoin | Phenytoin | 27 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 26 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 26 | suppressed |
| Pregabalin | Pregabalin | 26 | suppressed |
| Atenolol | Atenolol | 25 | suppressed |
| Celecoxib | Celecoxib | 25 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 25 | 22 |
| Paroxetine Hcl | Paroxetine Hcl | 24 | suppressed |
| Baclofen | Baclofen | 23 | suppressed |
| Myrbetriq | Mirabegron | 23 | suppressed |
| Naproxen | Naproxen | 23 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 23 | suppressed |
| Semglee (Yfgn) Pen | Insulin Glargine-Yfgn | 22 | suppressed |
| Verapamil Er | Verapamil Hcl | 21 | suppressed |
| Amoxicillin | Amoxicillin | 20 | 18 |
| Clonidine Hcl | Clonidine Hcl | 20 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 20 | suppressed |
| Latanoprost | Latanoprost | 20 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 20 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 20 | suppressed |
| Cartia Xt | Diltiazem Hcl | 19 | suppressed |
| Cilostazol | Cilostazol | 19 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 19 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 19 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 19 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 19 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 18 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 18 | suppressed |
| Clonazepam | Clonazepam | 18 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 18 | suppressed |
| Estradiol | Estradiol | 18 | suppressed |
| Stiolto Respimat | Tiotropium Br/Olodaterol Hcl | 18 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 18 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 17 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 17 | 14 |
| Aripiprazole | Aripiprazole | 17 | suppressed |
| Lovastatin | Lovastatin | 17 | suppressed |
| Nystatin | Nystatin | 17 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 17 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 17 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 16 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 16 | 12 |
| Ventolin Hfa | Albuterol Sulfate | 16 | suppressed |
| Risperidone | Risperidone | 15 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 15 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 15 | suppressed |
| Cephalexin | Cephalexin | 14 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 14 | suppressed |
| Lactulose | Lactulose | 14 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 14 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 14 | suppressed |
| Ozempic | Semaglutide | 14 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 14 | suppressed |
| Carbinoxamine Maleate | Carbinoxamine Maleate | 13 | suppressed |
| Eszopiclone | Eszopiclone | 13 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 13 | suppressed |
| Levofloxacin | Levofloxacin | 13 | 11 |
| Spiriva Respimat | Tiotropium Bromide | 13 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 13 | suppressed |
| Xarelto | Rivaroxaban | 13 | suppressed |
| Amantadine | Amantadine Hcl | 12 | suppressed |
| Carbamazepine | Carbamazepine | 12 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 12 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 12 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 12 | suppressed |
| Atrovent Hfa | Ipratropium Bromide | 11 | suppressed |
| Breyna | Budesonide/Formoterol Fumarate | 11 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 11 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 11 | suppressed |
| Methylprednisolone | Methylprednisolone | 11 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $35.67 · 2 records | Dexcom, Inc. | Dexcom G6 Transmitter, EVENITY | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error